HomeTagsMedicine

Medicine - Page 16

Stories from Medicine come first, newest first, then stories from connected topics (AI Science & Health, Healthcare, Hub: Tech for Good, healthcare AI, Biotech, drug discovery), each labelled with where it comes from. This view is not indexed by search engines.

Latest

Deep Origin and BioAge Labs Team Up on AI Drug Discovery, With First Hits Confirmed in the Lab

Deep Origin says its AI found drug hits against a new BioAge Labs target that BioAge has confirmed in the lab, in a new multi-target collaboration.

Baker Lab Uses AI to Design Enzymes That Cut Specific Proteins

Two Nature papers from David Baker's lab describe AI-designed enzymes that cut chosen proteins, including ones linked to disease. They are not treatments.

Ampath Confirms a Cybersecurity Incident; Attacker Claims It Stole More Than 80 Million Patient Records

South African lab Ampath confirms a cybersecurity incident that may have exposed patient data. Attacker ByteToBreach claims over 80 million records.

Generate Biomedicines and Zealand Pharma Team Up to Design Obesity Protein Drugs With AI

Zealand Pharma will pay Generate Biomedicines $30M upfront to design AI-engineered protein drugs for obesity, with milestones worth nearly $1.2 billion.

Agilent Agrees to Buy Proscia, an AI Digital Pathology Company, for $240 Million Plus Up to $30 Million More

Agilent will buy AI digital pathology firm Proscia for $240M in cash at closing plus up to $30M in milestone payments, the companies said on 13 Oct 2026.

Seqera Launches Nextflow Frontier, an AI System That Runs Thousands of Biology Experiments

Seqera has launched Nextflow Frontier, an AI system that runs thousands of biology experiments. Its benchmark results are Seqera's own claims.

Firmus Pulls Its ASX IPO as Isomorphic Labs Eyes a $40bn Valuation

Three AI business items from 8–9 October 2026: Nvidia-backed Firmus withdraws its ASX listing and turns to private money; Bloomberg reports Isomorphic Labs is in early funding talks at a valuation of at least $40 billion; and StepFun's Step 5 Preview model is now listed on OpenRouter and Vercel's AI Gateway. What is confirmed, and what is only reported.

AI in Medicine: Google’s AMIE in The Lancet, Chai and GSK, and an FDA-Cleared Autism Assessment Aid

Three AI-in-medicine items from 8–9 October 2026: a peer-reviewed Lancet feasibility study of Google's AMIE chatbot in real primary care, a company-announced collaboration between Chai Discovery and GSK on AI-designed proteins, and FDA clearance for Argus Cognitive's Neurora, an aid for clinicians that is not a stand-alone diagnostic tool. What each shows, and its limits.

Cyber Breaches, 9 October 2026: A Biotech’s Old Cloud, a Turkish University and a Louisiana Clinic

Three newly disclosed incidents: Ginkgo Bioworks says an outsider accessed data from cloud environments tied to its former biosecurity business; Turkey's data regulator says a ransomware attack on Yıldız Technical University may affect about 140,000 students and 4,500 staff; and Green Clinic in Ruston, Louisiana, is rebuilding after ransomware locked its records. What each organisation has confirmed.

UK healthcare AI: all 44 recommendations accepted, Airlock Phase 3 opens

The UK government said it will accept all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, and the MHRA opened AI Airlock Phase 3 applications focused on post-market surveillance.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.